Biotechnology: CRISPR–Cas becoming more human

Published on Sep 1, 2017in Nature Reviews Drug Discovery57.618
· DOI :10.1038/nrd.2017.167
  • References (1)
  • Citations (0)
📖 Papers frequently viewed together
20 Citations
3 Citations
78% of Scinapse members use related papers. After signing in, all features are FREE.
#1Hong Ma (Oregon National Primate Research Center)H-Index: 27
#2Nuria Marti-Gutierrez (OHSU: Oregon Health & Science University)H-Index: 1
Last. Shoukhrat MitalipovH-Index: 36
view all 31 authors...
CRISPR–Cas9 genome editing is used to induce a DNA repair response and correct a disease-causing heterozygous mutation in human embryos with reduced mosaicism and preferential repair using the wild-type copy of the gene.
328 CitationsSource
Cited By0